Year-End Report 12 months – 1 January-31 December 2025

ITAB reported FY2025 net sales up 94% to MSEK 12,780 (organic +4%, acquisition of HMY +93%) and EBITDA excl. non‑recurring items of MSEK 1,267 (761), with operating profit MSEK 580 (459) and an operating margin of 4.5% (7.0). Profit after tax fell to MSEK 158 (320) and EPS to SEK 0.51 (1.38), while cash flow from operations strengthened to MSEK 785; net debt excluding leases swung to MSEK 2,332 (from -969) and the Board proposes no dividend. The year was shaped by the HMY acquisition (closed 31 Jan 2025), further tuck‑ins (Signatrix, Blink), major retail rollouts and CEO turnover (interim CEO in place, new CEO appointed effective May 1, 2026), leaving a mixed picture of strong top‑line/pro forma performance but higher leverage and one‑off charges.

Analysis

Market structure: The HMY acquisition makes ITAB (ITAB Group) a clear consolidator in retail fixtures, self-checkout and loss-prevention solutions — winners include ITAB (scale, cross-sell) and large grocery chains getting integrated solutions; losers are small local fit-out vendors and legacy checkout-only suppliers. Pro forma sales ~SEK13.3bn and adjusted EBIT margin 6.4% imply material pricing and bid advantage in large roll-outs (200+ stores UK, 500+ Australia), but near-term pricing power is muted by integration costs and supplier lead times for electronics.

Risk assessment: Key tail risks are (1) integration failure or >SEK1–2bn goodwill/impairment charges, (2) covenant pressure from net-debt ~MSEK2,332 (vs net cash prior year), and (3) client-concentration workout if one major grocery rollout stalls. Near-term (days-weeks) expect event-driven volatility; short-term (3–9 months) the balance sheet and cash conversion will be tested; long-term (12–36 months) value depends on synergy capture and margin re-rating to >7.5%.

Trade implications: Tactical trades should size conservatively and hedge. If you believe integration executes, a modest long-equity position hedged with puts or a bullish call-spread captures upside from margin recovery; conversely, buy credit protection or underweight ITAB bonds if senior yields are <6% given leverage. Catalysts to watch for entry/exit: Q1 trading update (within 6–10 weeks), CEO transition outcomes (1 May 2026), and delivery milestones for UK/Australia roll-outs.

Contrarian angles: The market may over-penalize ITAB for leverage and lump all non-recurring costs into recurring weakness — but if pro forma adjusted EBIT (MSEK847) can be pushed toward 8% margin within 12–18 months, equity upside is significant. Hidden risks include receivables and warranty-driven working capital spikes during roll-outs; conversely, quick cross-sell of Signatrix AI and Blink design could de-risk growth and be underappreciated by consensus.

Key Decisions for Investors

• Establish a 2–3% long position in ITAB equity (ITAB.ST) within the next 2 weeks, paired with a 3-month 10% OTM put to cap downside (stop-loss ~15%). Rationale: pro forma scale and orderbook (UK 200 stores, Australia 500 stores) provide upside if margins normalize to ~7.5% in 12–18 months.
• If you prefer lower cash outlay, buy a 9–12 month ITAB call spread (buy 12-month ATM call, sell 12-month 30% OTM call) sized at 1–2% portfolio risk to capture margin re-rating while limiting premium spend; reassess after Q1 trading update (expected within 6–10 weeks).
• Reduce/avoid exposure to ITAB corporate bonds or new issues maturing 2027–2029 unless yield ≥6.5%; alternatively buy 1–2 year CDS protection or credit-default swaps as a hedge if available, because net debt moved to MSEK2,332 and covenant/leverage risk is elevated.
• Pair trade (relative value): Long ITAB (1–2%) vs short a lower-tech retail-fixture peer (size matched) for 6–12 months to isolate premium for scale-integration optionality; exit or rebalance on CEO strategic plan release (by 1 May 2026) or if cash conversion drops >20% q/q.